NCT00427141View on ClinicalTrials.gov

A Three-Part Study Of GSK580416 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2006

Conditions
Respiratory Tract InfectionInfections, Bacterial
Interventions
DRUG

GSK580416

Trial Locations (1)

2031

GSK Investigational Site, Randwick, Sydney

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY